GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Assets | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr | ₹4,086 Cr |
What is the latest Total Assets ratio of GLAND PHARMA ?
Year | Total Assets |
---|---|
Mar2024 | ₹10,611 Cr |
Mar2023 | ₹8,778 Cr |
Mar2022 | ₹7,834 Cr |
Mar2021 | ₹6,496 Cr |
Mar2020 | ₹4,086 Cr |
How is Total Assets of GLAND PHARMA Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹10,611 Cr | 20.89 | |
Mar2023 | ₹8,778 Cr | 12.05 | |
Mar2022 | ₹7,834 Cr | 20.59 | |
Mar2021 | ₹6,496 Cr | 58.98 | |
Mar2020 | ₹4,086 Cr | - |
Compare Total Assets of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹30,881.0 Cr | 2.3% | 15% | 3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 2.3% |
15% |
3.4% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses